These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36786305)

  • 1. Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study.
    Tancin Lambert A; Ratajczak-Tretel B; Al-Ani R; Arntzen K; Bakkejord GK; Bekkeseth HMO; Bjerkeli V; Eldøen G; Gulsvik AK; Halvorsen B; Høie GA; Ihle-Hansen H; Ihle-Hansen H; Ingebrigtsen S; Johansen H; Kremer C; Krogseth SB; Kruuse C; Kurz M; Nakstad I; Novotny V; Naess H; Qazi R; Rezai MK; Rørholt DM; Steffensen LH; Sømark J; Tobro H; Truelsen TC; Wassvik L; AEgidius KL; Pesonen M; de Melis M; Atar D; Aamodt AH;
    Eur J Neurol; 2023 May; 30(5):1352-1363. PubMed ID: 36786305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
    Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
    Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.
    Kneihsl M; Gattringer T; Bisping E; Scherr D; Raggam R; Mangge H; Enzinger C; Fandler-Höfler S; Eppinger S; Hermetter C; Bucnik B; Poltrum B; Niederkorn K; Fazekas F
    Stroke; 2019 Aug; 50(8):2223-2226. PubMed ID: 31216968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide and D-dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation.
    Shen Z; Chen D; Cheng H; Tan F; Yan J; Deng H; Fang W; Wang S; Zhu J
    Clin Cardiol; 2023 Jan; 46(1):41-48. PubMed ID: 36208092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study.
    Ratajczak-Tretel B; Lambert AT; Al-Ani R; Arntzen K; Bakkejord GK; Bekkeseth HMO; Bjerkeli V; Eldøen G; Gulsvik AK; Halvorsen B; Høie GA; Ihle-Hansen H; Ihle-Hansen H; Ingebrigtsen S; Kremer C; Krogseth SB; Kruuse C; Kurz M; Nakstad I; Novotny V; Næss H; Qazi R; Rezaj MK; Rørholt DM; Steffensen LH; Sømark J; Tobro H; Truelsen TC; Wassvik L; Ægidius KL; Atar D; Aamodt AH;
    J Neurol; 2023 Aug; 270(8):4049-4059. PubMed ID: 37162578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort Studies.
    Cameron AC; Arnold M; Katsas G; Yang J; Quinn TJ; Abdul-Rahim AH; Campbell R; Docherty K; De Marchis GM; Arnold M; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Foerch C; Spanaus K; Eckardstein AV; Dawson J; Katan M
    Neurology; 2024 Aug; 103(3):e209625. PubMed ID: 38950311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke.
    Diener HC; Wachter R; Wong A; Thijs V; Schnabel RB; Ntaios G; Kasner S; Rothwell PM; Passman R; Saver JL; Albers BA; Bernstein RA
    Int J Stroke; 2023 Apr; 18(4):400-407. PubMed ID: 36050817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SERUM cardiac-specific biomarkers and atrial fibrillation in myotonic dystrophy type I.
    Russo V; Rago A; Atripaldi L; Leonardi S; Papa AA; Politano L; Golino P; Potpara TS; Nigro G
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2914-2919. PubMed ID: 31579995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide shows diagnostic accuracy for detecting atrial fibrillation in cryptogenic stroke patients.
    Fonseca AC; Brito D; Pinho e Melo T; Geraldes R; Canhão P; Caplan LR; Ferro JM
    Int J Stroke; 2014 Jun; 9(4):419-25. PubMed ID: 23981586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study.
    Tancin Lambert A; Kong XY; Ratajczak-Tretel B; Atar D; Russell D; Skjelland M; Bjerkeli V; Skagen K; Coq M; Schordan E; Firat H; Halvorsen B; Aamodt AH
    Cerebrovasc Dis Extra; 2020; 10(1):11-20. PubMed ID: 32028277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: A retrospective multicenter case-control study.
    Zhao J; Zhang Y; Yuan F; Song C; Jiang Y; Gao Q; Leng X; Jiang W
    J Neurol Sci; 2020 Jul; 414():116822. PubMed ID: 32278166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
    J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results.
    Ratajczak-Tretel B; Tancin Lambert A; Al-Ani R; Arntzen K; Bakkejord GK; Bekkeseth H; Bjerkeli V; Eldøen G; Gulsvik A; Halvorsen B; Høie GA; Ihle-Hansen H; Ihle-Hansen H; Ingebrigtsen S; Johansen H; Kremer C; Krogseth SB; Kruuse C; Kurz M; Nakstad I; Novotny V; Næss H; Qazi R; Rezaj MK; Rørholt DM; Steffensen LH; Sømark J; Tobro H; Truelsen TC; Wassvik L; Ægidius KL; Atar D; Aamodt AH
    Eur Stroke J; 2023 Mar; 8(1):148-156. PubMed ID: 37021182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting atrial fibrillation after cryptogenic stroke via a clinical risk score-a prospective observational study.
    Kneihsl M; Bisping E; Scherr D; Mangge H; Fandler-Höfler S; Colonna I; Haidegger M; Eppinger S; Hofer E; Fazekas F; Enzinger C; Gattringer T
    Eur J Neurol; 2022 Jan; 29(1):149-157. PubMed ID: 34519135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Utility of N-Terminal Pro-B-Type Natriuretic Peptide in Identifying Atrial Fibrillation Post-Cryptogenic Stroke: A Systematic Review and Meta-Analysis.
    Patel J; Bhaskar SMM
    Pathophysiology; 2024 Jun; 31(3):331-349. PubMed ID: 39051222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.
    Kerr B; Brandon L
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101132. PubMed ID: 36246770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP cut-off value for ruling out heart failure in atrial fibrillation patients - A prospective clinical study.
    Budolfsen C; Schmidt AS; Lauridsen KG; Hoeks CB; Waziri F; Poulsen CB; Riis DN; Rickers H; Løfgren B
    Am J Emerg Med; 2023 Sep; 71():18-24. PubMed ID: 37320999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
    Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
    BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study.
    Xing LY; Diederichsen SZ; Højberg S; Krieger DW; Graff C; Frikke-Schmidt R; Olesen MS; Brandes A; Køber L; Haugan KJ; Svendsen JH
    Circulation; 2023 Jun; 147(24):1788-1797. PubMed ID: 37061802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.